/persons/resource/persons147193
Heuckmann,
Johannes M.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
Hölzel,
Michael
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany
b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands
c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States
d Chemical Genomics Center, Max Planck Society, Dortmund, Germany
e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany
f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;
/persons/resource/persons147301
Sos,
Martin L.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
/persons/resource/persons147194
Heynck,
Stefanie
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
/persons/resource/persons147128
Balke-Want,
Hyatt
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
/persons/resource/persons147213
Koker,
Mirjam
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
/persons/resource/persons147255
Peifer,
Martin
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
/persons/resource/persons147338
Weiss,
Jonathan
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
Lovly,
Christine M.
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany
b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands
c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States
d Chemical Genomics Center, Max Planck Society, Dortmund, Germany
e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany
f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;
Grütter,
Christian
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany
b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands
c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States
d Chemical Genomics Center, Max Planck Society, Dortmund, Germany
e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany
f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;
Rauh,
Daniel
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany
b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands
c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States
d Chemical Genomics Center, Max Planck Society, Dortmund, Germany
e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany
f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;
Pao,
William
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany
b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands
c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States
d Chemical Genomics Center, Max Planck Society, Dortmund, Germany
e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany
f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;
/persons/resource/persons147315
Thomas,
Roman K.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;